Ellen Dayon, MD Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1661 Golden Rain Rd, Seal Beach, CA 90740 Phone: 562-493-9581 |
Mary B Sherman, MD Internal Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 1661 Golden Rain Rd, Seal Beach, CA 90740 Phone: 562-493-9581 |
Dr. Sophia Chun, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1661 Golden Rain Rd, Seal Beach, CA 90740 Phone: 562-493-9581 Fax: 562-795-6397 |
Dr. Steven Joseph Becker, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13930 Seal Beach Blvd, Seal Beach, CA 90740 Phone: 562-430-8888 Fax: 562-799-0077 |
Christopher P Nguyen, MD Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 13930 Seal Beach Blvd, Seal Beach, CA 90740 Phone: 562-430-8888 Fax: 562-799-0077 |
Prakash Narain, MD Internal Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 1661 Golden Rain Rd, Seal Beach, CA 90740 Phone: 562-493-9581 Fax: 562-430-6795 |
Dr. George Somlo, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1601 Island View Dr, Seal Beach, CA 90740 Phone: 562-596-6038 |
News Archive
The first step in treating cancer is understanding how it starts, grows and spreads throughout the body. A relatively new cancer research approach is the study of metabolites, the products of different steps in cancer cell metabolism, and how those substances interact.
More than 115 Americans die every day of opioid overdose. Many more survive thanks to the antidote medication, naloxone. But a study out Monday finds that just 3 in 10 patients revived by an EMT or in an emergency room received the follow-up medication known to avoid another life-threatening event.
DNA assembled into nanostructures such as tubes and origami-inspired shapes could someday find applications ranging from DNA computers to nanomedicine.
AMRI today reported financial and operating results for the second quarter ended June 30, 2015. "We are very pleased to present another strong financial quarter, with all our divisions achieving excellent results," said William S. Marth, AMRI's president and chief executive officer. "Notably, recent acquisitions, combined with the cost reduction initiatives and efficiency efforts we've made to date, are contributing to continued strong contract margin performance.
Blood freezing technology, developed at Warwick, has been shortlisted in a Royal Society of Chemistry competition to find promising emerging technologies. Warwick Ventures is working with the researchers to identify commercial opportunities for the technique.
› Verified 7 days ago